Bioanalytical Systems Stock – Fundamental Analysis
Not enough price data available yet.
Fundamental Data & Ratios (Balance sheet update: 12/29/2020)
| Balance Sheet | Total Assets | 61,593,000.00 | ROE | – |
| Balance Sheet | Total Equity | 7,596,000.00 | ROA | – |
| Cashflow | Capital Expenditures | -6,200,000.00 | P/FCF | – |
| Cashflow | Free Cash Flow | -4,910,000.00 | – | – |
| Cashflow | Operating Cash Flow | 1,290,000.00 | P/CF | – |
| Income | Earnings per Share (diluted) | -0.43 | Div. Yield | – |
| Income | Net Income | -4,685,000.00 | P/E | – |
| Income | Shares Outstanding | 10,851,000.00 | P/B | – |
| Income | Total Revenue | 60,469,000.00 | P/S | – |
Ratios calculated on: –
Company Description
Bioanalytical Systems, Inc. is a contract research company providing drug discovery and development services. The Company´s clients and partners include pharmaceutical, biotechnology, academic and Government organizations. It derives its revenues from sales of its research services and drug development tools. The Company has been involved in the research of drugs to treat a number of therapeutic areas. It supports the preclinical and clinical development needs of researchers and clinicians for small molecule and large biomolecule drug candidates. Its principal clients are scientists engaged in analytical chemistry, drug safety evaluation, clinical trials, drug metabolism studies, pharmacokinetics and basic research, including biotechnology companies and pharmaceutical companies. It operates in two business segments: contract research services and research products, both of which address the bioanalytical, preclinical, and clinical research needs of drug developers.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.basinc.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more